Literature DB >> 8546869

Hypoxic and metabolic regulation of voltage-gated K+ channels in rat pulmonary artery smooth muscle cells.

X J Yuan1, M L Tod, L J Rubin, M P Blaustein.   

Abstract

Inhibition of voltage-gated K+ (Kv) channels by 4-aminopyridine (4-AP) depolarizes pulmonary artery (PA) smooth muscle cells, induces Ca(2+)-dependent action potentials and increases [Ca2+]i. Neither charybdotoxin, which blocks Ca(2+)-activated K+ channels, nor glibenclamide, which blocks ATP-sensitive K+ channels, has such effects on membrane potential (Em) and [Ca2+]i. Hypoxia reversibly decreases the 4-AP-sensitive KV currents (IK(V)) in PA myocytes. The resulting membrane depolarization caused by decreased IK(V) induces Ca(2+)-dependent action potentials and thereby raises [Ca2+]i. Thus, KV channel activity plays a critical role in: (a) regulating Em and [Ca2+]i under physiological conditions; and (b) sensing O2 alteration and transducing the hypoxic stimulus to changes of Em and [Ca2+]i. The metabolic inhibitors 2-deoxy-D-glucose (2-DOG; 10 mM) and carbonyl cyanide-p-trifluoromethoxyphenyl-hydrazone (FCCP; 3-5 microM), the reducing agent reduced glutathione and inhibitors of cytochrome P-450, all mimic the effects of hypoxia on IK(V) and Em in PA myocytes. Furthermore, hypoxia and 2-DOG negligibly affect IK(V) and Em in mesenteric artery smooth muscle cells. These results suggest that hypoxia, perhaps via a localized reduction of ATP, triggers the block of KV channels and depolarizes PA myocytes. This blockade may also be mediated by a change in cellular redox status, perhaps via a conformational change of a haem- (or metal-) containing regulatory moiety that is attached to the channel protein.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8546869     DOI: 10.1113/expphysiol.1995.sp003888

Source DB:  PubMed          Journal:  Exp Physiol        ISSN: 0958-0670            Impact factor:   2.969


  10 in total

Review 1.  Ca(2+) and ion channels in hypoxia-mediated pulmonary hypertension.

Authors:  Ning Lai; Wenju Lu; Jian Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-02-01

Review 2.  Phases and Mechanisms of Embryonic Cardiomyocyte Proliferation and Ventricular Wall Morphogenesis.

Authors:  Yaacov Barak; Myriam Hemberger; Henry M Sucov
Journal:  Pediatr Cardiol       Date:  2019-07-24       Impact factor: 1.655

3.  Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.

Authors:  Haiyang Tang; Jiwang Chen; Dustin R Fraidenburg; Shanshan Song; Justin R Sysol; Abigail R Drennan; Stefan Offermanns; Richard D Ye; Marcelo G Bonini; Richard D Minshall; Joe G N Garcia; Roberto F Machado; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464

4.  Cellular localization of mitochondria contributes to Kv channel-mediated regulation of cellular excitability in pulmonary but not mesenteric circulation.

Authors:  Amy L Firth; Dmitri V Gordienko; Kathryn H Yuill; Sergey V Smirnov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-19       Impact factor: 5.464

5.  Kv2.1/Kv9.3, a novel ATP-dependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes.

Authors:  A J Patel; M Lazdunski; E Honoré
Journal:  EMBO J       Date:  1997-11-17       Impact factor: 11.598

Review 6.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

7.  Dehydroepiandrosterone (DHEA) prevents and reverses chronic hypoxic pulmonary hypertension.

Authors:  Sébastien Bonnet; Eric Dumas-de-La-Roque; Hugues Bégueret; Roger Marthan; Michael Fayon; Pierre Dos Santos; Jean-Pierre Savineau; Etienne-Emile Baulieu
Journal:  Proc Natl Acad Sci U S A       Date:  2003-07-23       Impact factor: 11.205

8.  Mitochondria-dependent regulation of Kv currents in rat pulmonary artery smooth muscle cells.

Authors:  Amy L Firth; Kathryn H Yuill; Sergey V Smirnov
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-05-09       Impact factor: 5.464

9.  Regulation of ca(2+) signaling in pulmonary hypertension.

Authors:  Amy L Firth; Jun Yeon Won; Won Sun Park
Journal:  Korean J Physiol Pharmacol       Date:  2013-02-14       Impact factor: 2.016

Review 10.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.